AAAAAA

   
Results: 1-11 |
Results: 11
CONGENITAL TOXOPLASMOSIS - EFFICACY OF MATERNAL TREATMENT WITH SPIRAMYCIN ALONE
Authors: VERGANI P GHIDINI A CERUTI P STROBELT N SPELTA A ZAPPAROLI B RESCALDANI R
Citation: P. Vergani et al., CONGENITAL TOXOPLASMOSIS - EFFICACY OF MATERNAL TREATMENT WITH SPIRAMYCIN ALONE, AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 39(5), 1998, pp. 335-340
EVALUATION OF HCVAB IN BLOOD-DONORS - A SURVEY OF ITALIAN TRANSFUSIONCENTERS (TC)
Authors: MASCARETTI L CAZZANIGA G VECCHI L RESCALDANI R CONFALONIERI G SCIORELLI G
Citation: L. Mascaretti et al., EVALUATION OF HCVAB IN BLOOD-DONORS - A SURVEY OF ITALIAN TRANSFUSIONCENTERS (TC), Transfusion, 38(10), 1998, pp. 222-222
HIGH-INCIDENCE OF ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PYOGENES IN MONZA (NORTH ITALY) IN UNTREATED CHILDREN WITH SYMPTOMS OF ACUTE PHARYNGO-TONSILLITIS - AN EPIDEMIOLOGIC AND MOLECULAR STUDY
Authors: COCUZZA CE MATTINA R MAZZARIOL A OREFICI G RESCALDANI R PRIMAVERA A BRAMATI S MASERA G PARIZZI F CORNAGLIA G FONTANA R
Citation: Ce. Cocuzza et al., HIGH-INCIDENCE OF ERYTHROMYCIN-RESISTANT STREPTOCOCCUS-PYOGENES IN MONZA (NORTH ITALY) IN UNTREATED CHILDREN WITH SYMPTOMS OF ACUTE PHARYNGO-TONSILLITIS - AN EPIDEMIOLOGIC AND MOLECULAR STUDY, Microbial drug resistance, 3(4), 1997, pp. 371-378
CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS
Authors: LISSONI P BRIVIO F PITTALIS S ROVELLI F RESCALDANI R PEREGO MS GRASSI MG BARNI S TANCINI G MAJORCA F FUMAGALLI L
Citation: P. Lissoni et al., CLINICAL-SIGNIFICANCE OF ERYTHROSEDIMENTATION RATE IN CANCER IN RELATION TO CYTOKINE PRODUCTION - CORRELATION WITH HIGH IL-6 AND LOW IL-2 BLOOD-CONCENTRATIONS, Journal of biological regulators and homeostatic agents, 10(2-3), 1996, pp. 60-62
PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA
Authors: BRIVIO F LISSONI P FUMAGALLI L BRIVIO O LAVORATO F RESCALDANI R CONTI A ROSELLI MG MAESTRONI G BARNI S
Citation: F. Brivio et al., PREOPERATIVE NEUROIMMUNOTHERAPY WITH SUBCUTANEONS LOW-DOSE INTERLEUKIN-2 AND MELATONIN IN PATIENTS WITH GASTROINTESTINAL TUMORS - ITS EFFICACY IN PREVENTING SURGERY-INDUCED LYMPHOCYTOPENIA, Oncology Reports, 2(4), 1995, pp. 597-599
NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/
Authors: LISSONI P VIGORE L RESCALDANI R ROVELLI F BRIVIO F GIANI L BARNI S TANCINI G ARDIZZOIA A VIGANO MG
Citation: P. Lissoni et al., NEUROIMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS MELATONIN IN AIDS PATIENTS WITH CD4 CELL NUMBER BELOW 200 MM(3) - A BIOLOGICAL PHASE-II STUDY/, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 155-158
LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2
Authors: LISSONI P BARNI S ANDRES M SCARDINO E VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285
LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2
Authors: LISSONI P BARNI S ANDRES M SCARDINO E VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: P. Lissoni et al., LYMPHOCYTOSIS DECLINE IS NOT RESPONSIBLE FOR TUMOR PROGRESSION IN CANCER-PATIENTS CHRONICALLY TREATED WITH INTERLEUKIN-2, Tumori, 80(4), 1994, pp. 283-285
A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA
Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A RICCI G ALDEGHI R BRIVIO F TISI E ROVELLI F RESCALDANI R QUADRO G MAESTRONI G
Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199
INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER
Authors: LISSONI P BARNI S TISI E ROVELLI F PITTALIS S RESCALDANI R VIGORE L BIONDI A ARDIZZOIA A TANCINI G
Citation: P. Lissoni et al., INVIVO BIOLOGICAL RESULTS OF THE ASSOCIATION BETWEEN INTERLEUKIN-2 AND INTERLEUKIN-3 IN THE IMMUNOTHERAPY OF CANCER, European journal of cancer, 29A(8), 1993, pp. 1127-1132
IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA
Authors: BARNI S LISSONI P ARDIZZOLA A VIGORE L VEZZO R RESCALDANI R TANCINI G
Citation: S. Barni et al., IMMUNOTHERAPY WITH LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 PLUS INTERFERON-BETA AS A 2ND-LINE THERAPY FOR METASTATIC COLORECTAL-CARCINOMA, Tumori, 79(5), 1993, pp. 343-346
Risultati: 1-11 |